Tempest Suspends Group Activities After 4 Years… Hyuk Enlists in the Military, Ru’s Contract Expires
YH Entertainment: “Decision Made After Discussions with Members”
Hyuk to Enlist on the 26th; LEW Contract Ends on the 1st of Next Month
Han-bin, Hyung-seop, Eun-chan, and Tae-rae Focus on Individual Activities
[Edaily Starin YUN GI BACK Reporter] The group TEMPEST is suspending group activities and members will pursue individual projects. Member Hyuk will enlist on the 26th, and LEW is leaving the agency. TEMPEST (Photo: News1) Their agency, YH Entertainment, announced in a statement on the 20th, “After careful and lengthy discussions with the members, we have decided to suspend group activities and focus on each member’s individual activities going forward.” Accordingly, Hyuk will enlist on the 26th to fulfill his mandatory military service. No separate official event will be held on the day of his enlistment. The agency asked fans to refrain from visiting the site out of consideration for other recruits and their families. Roo’s exclusive contract with YH Entertainment will expire on November 1. The agency expressed, “We sincerely thank Roo for his time with us,” and wished him well in his new endeavors. Hanbin, Hyungsub, Eunchan, and Taerae will focus on individual activities for the time being. The agency plans to continue providing the necessary support so that they can showcase new sides of themselves in their respective fields. YH Entertainment stated, “We will never forget the time we spent together as TEMPEST or the precious love our fans have shown us,” adding, “We sincerely apologize for causing concern with this sudden news.” TEMPEST is a boy group that debuted in March 2022. They have promoted with songs such as “Bad News,” “Dragon,” and “Vroom Vroom.”
HANWHA SYSTEMS(272210)has secured 1.4 trillion won in liquidity by disposing of its remaining stake in Hanwha Ocean(042660) through a Price Return Swap (PRS) arrangement, but some observers point out …
Shinsegae Co.,Ltd(004170) CJ Corp.(001040)CJ Group and Shinsegae have joined forces to enter the race to acquire the JoongAng Ilbo. Attention is focused on the reasons behind the decision by these two…
Huons Co., Ltd.(243070)has confirmed the ability to inhibit intestinal fibrosis in preclinical trials of “HUC1A-626,” a drug candidate for fibrosing Crohn’s disease currently under development. Unlike…